Literature DB >> 31396325

miRNA-574-3p inhibits metastasis and chemoresistance of epithelial ovarian cancer (EOC) by negatively regulating epidermal growth factor receptor (EGFR).

Pengnan Zhang1,2, Jie Zhu1,2, Ya Zheng1,2, Haiyan Zhang1,2, Hong Sun1,2, Shujun Gao1,2,3.   

Abstract

BACKGROUND: This current study explored the role of miRNA-574-3p and the related molecular mechanisms in epithelial ovarian cancer (EOC).
METHODS: Tissues of ovarian cancer patients were applied to explore the correlation between miRNA-574-3p and EOC. The role of miRNA-574-3p in migration, invasion and chemoresistance of EOC cells was evaluated by overexpression and suppression of miRNA-574-3p in SKOV3 and CAOV3 cells. For the sake of exploring how miRNA-574-3p regulated tumor migration, invasion and chemoresistance of EOC cells, we detected several related molecular expressions and activities of signaling pathways.
RESULTS: Overexpression of epidermal growth factor receptor (EGFR) was correlated with downregulation of miR-574-3p in EOC tissues. Overexpression of miRNA-574-3p in EOC cells led to inhibition of cell migration as well as invasion, and it significantly promoted the sensitivities of EOC cells to paclitaxel and cisplatin. Molecular experiments showed miR-574-3p inhibited activation of AKT, FAK and c-Src, as well as MMP-9 expression via targeting EGFR.
CONCLUSION: Taken together, these data demonstrated that miRNA-574-3p inhibits both tumor metastasis and chemoresistance in EOC via targeting EGFR. Thus, targeting miRNA-574-3p may become a potential molecular method for EOC.

Entities:  

Keywords:  EGFR; epithelial ovarian cancer; miR-574-3p; microRNA

Year:  2019        PMID: 31396325      PMCID: PMC6684900     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  27 in total

1.  Regulation by let-7 and lin-4 miRNAs results in target mRNA degradation.

Authors:  Shveta Bagga; John Bracht; Shaun Hunter; Katlin Massirer; Janette Holtz; Rachel Eachus; Amy E Pasquinelli
Journal:  Cell       Date:  2005-08-26       Impact factor: 41.582

Review 2.  MicroRNA and ovarian cancer.

Authors:  David C Corney; Alexander Yu Nikitin
Journal:  Histol Histopathol       Date:  2008-09       Impact factor: 2.303

3.  Maintenance therapy for ovarian cancer: of Helsinki and Hippocrates.

Authors:  William Patrick McGuire
Journal:  J Clin Oncol       Date:  2009-08-24       Impact factor: 44.544

4.  The epidermal growth factor receptor responsive miR-125a represses mesenchymal morphology in ovarian cancer cells.

Authors:  Karen D Cowden Dahl; Richard Dahl; Jessica N Kruichak; Laurie G Hudson
Journal:  Neoplasia       Date:  2009-11       Impact factor: 5.715

Review 5.  Untangling the ErbB signalling network.

Authors:  Y Yarden; M X Sliwkowski
Journal:  Nat Rev Mol Cell Biol       Date:  2001-02       Impact factor: 94.444

6.  Epidermal growth factor receptor signaling and the invasive phenotype of ovarian carcinoma cells.

Authors:  E S Bergmann-Leitner; T A Bennett; N F Hacker; K Stromberg; W G Stetler-Stevenson
Journal:  J Natl Cancer Inst       Date:  2001-09-19       Impact factor: 13.506

7.  Ovarian cancer in Europe: Cross-sectional trends in incidence and mortality in 28 countries, 1953-2000.

Authors:  Freddie Bray; Anja Helena Loos; Sandro Tognazzo; Carlo La Vecchia
Journal:  Int J Cancer       Date:  2005-03-01       Impact factor: 7.396

8.  Prognostic significance of p53, Her-2, and EGFR overexpression in borderline and epithelial ovarian cancer.

Authors:  J S Nielsen; E Jakobsen; B Hølund; K Bertelsen; A Jakobsen
Journal:  Int J Gynecol Cancer       Date:  2004 Nov-Dec       Impact factor: 3.437

9.  A new prognostic model comprising p53, EGFR, and tumor grade in early stage epithelial ovarian carcinoma and avoiding the problem of inaccurate surgical staging.

Authors:  I Skírnisdóttir; T Seidal; B Sorbe
Journal:  Int J Gynecol Cancer       Date:  2004 Mar-Apr       Impact factor: 3.437

10.  The nuclear RNase III Drosha initiates microRNA processing.

Authors:  Yoontae Lee; Chiyoung Ahn; Jinju Han; Hyounjeong Choi; Jaekwang Kim; Jeongbin Yim; Junho Lee; Patrick Provost; Olof Rådmark; Sunyoung Kim; V Narry Kim
Journal:  Nature       Date:  2003-09-25       Impact factor: 49.962

View more
  9 in total

1.  LINC00997/MicroRNA 574-3p/CUL2 Promotes Cervical Cancer Development via Mitogen-Activated Protein Kinase Signaling.

Authors:  Daming Chu; Tengteng Liu; Yuan Yao; Nannan Luan
Journal:  Mol Cell Biol       Date:  2021-07-23       Impact factor: 4.272

2.  MiR-338-3p Enhances Ovarian Cancer Cell Sensitivity to Cisplatin by Downregulating WNT2B.

Authors:  Qin Niu; Zhenghong Liu; Jia Gao; Qiao Wang
Journal:  Yonsei Med J       Date:  2019-12       Impact factor: 2.759

Review 3.  Approaches Toward Targeting Matrix Metalloproteases for Prognosis and Therapies in Gynecological Cancer: MicroRNAs as a Molecular Driver.

Authors:  Anuradha Pandit; Yasmin Begum; Priyanka Saha; Amit Kumar Srivastava; Snehasikta Swarnakar
Journal:  Front Oncol       Date:  2022-01-25       Impact factor: 6.244

4.  Common miRNAs, candidate genes and their interaction network across four subtypes of epithelial ovarian cancer.

Authors:  Rinki Singh; Anup Som
Journal:  Bioinformation       Date:  2021-08-31

5.  ZEB1-AS1/miR-133a-3p/LPAR3/EGFR axis promotes the progression of thyroid cancer by regulating PI3K/AKT/mTOR pathway.

Authors:  Wu Xia; Wen Jie
Journal:  Cancer Cell Int       Date:  2020-03-29       Impact factor: 5.722

6.  circCELSR1 (hsa_circ_0063809) Contributes to Paclitaxel Resistance of Ovarian Cancer Cells by Regulating FOXR2 Expression via miR-1252.

Authors:  Shu Zhang; Jie Cheng; Chenlian Quan; Hao Wen; Zheng Feng; Qin Hu; Jun Zhu; Yan Huang; Xiaohua Wu
Journal:  Mol Ther Nucleic Acids       Date:  2019-12-18       Impact factor: 8.886

7.  An Anti-inflammatory microRNA Signature Distinguishes Group 3 Innate Lymphoid Cells From Natural Killer Cells in Human Decidua.

Authors:  Andrea Pelosi; Claudia Alicata; Nicola Tumino; Tiziano Ingegnere; Fabrizio Loiacono; Maria Cristina Mingari; Lorenzo Moretta; Paola Vacca
Journal:  Front Immunol       Date:  2020-02-06       Impact factor: 7.561

Review 8.  The Role of microRNAs in Epithelial Ovarian Cancer Metastasis.

Authors:  Vu Hong Loan Nguyen; Chenyang Yue; Kevin Y Du; Mohamed Salem; Jacob O'Brien; Chun Peng
Journal:  Int J Mol Sci       Date:  2020-09-25       Impact factor: 5.923

9.  Interleukin-18 promotes the antitumor ability of natural killer cells in colorectal cancer via the miR-574-3p/TGF-β1 axis.

Authors:  Yin-Peng Li; Xian-Rong Du; Ru Zhang; Qiu Yang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.